Publications by authors named "Li-xian Wu"

Claim this Profile
T
The SP1-SuperEnhancer-SPHK1 Axis Mediates Niraparib Resistance in TNBC.
Yu-Xia Yuan, Rui-Jia Chen, Gui-Hui Tu, Chao-Qi Li, Long-Long Xu, Li-Xian Wu

Pharmaceuticals (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A PARP1 PROTAC as a novel strategy against PARP inhibitor resistance via promotion of ferroptosis in p53-positive breast cancer.
Ge Li, Shan-Shan Lin, Ze-Lei Yu, Xin-Hua Wu, Jing-Wen Liu, Li-Xian Wu

Biochem Pharmacol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The microRNA miR-184 regulates the CYP303A1 transcript level to control molting of Locusta migratoria.
Yan-Li Wang, Li-Xian Wu, Hui-Yong Li, Xue-Qin Wen, En-Bo Ma

Insect Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro.
Li-xian Wu, Ying Wu, Rui-jia Chen, Yang Liu, Li-sen Huang

Acta Pharmacol Sin· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human urotensin II in internal mammary and radial arteries of patients undergoing coronary surgery.
Zhi-Wu Chen, Qin Yang, Yu Huang, Li Fan, Xian-Wu Li

Vascul Pharmacol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic engineering for ethylene production by inserting the ethylene-forming enzyme gene (efe) at the 16S rDNA sites of Pseudomonas putida KT2440.
Jian-Ping Wang, Li-Xian Wu, Feng Xu, Jing Lv, Hao-Jie Jin

Bioresour Technol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells.
Kun-Zhong Zhang, Jian-Hua Xu, Xiu-Wang Huang, Li-Xian Wu, Yu Su

Acta Pharmacol Sin· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of p210(bcr/abl) by curcumin involves disrupting molecular chaperone functions of Hsp90.
Li-Xian Wu, Jian-Hua Xu, Xiu-Wang Huang, Kun-Zhong Zhang, Cai-Xia Wen

Acta Pharmacol Sin· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory effect of curcumin on proliferation of K562 cells involves down-regulation of p210(bcr/abl) initiated Ras signal transduction pathway.
Li-Xian Wu, Jian-Hua Xu, Guo-Hua Wu, Yuan-Zhong Chen

Acta Pharmacol Sin· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis